The use of fondaparinux in preventing thromboembolism in high risk trauma patients

Trial Profile

The use of fondaparinux in preventing thromboembolism in high risk trauma patients

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2008 Actual patient number (106) added as reported by ClinicalTrials.gov.
    • 05 Oct 2008 Status changed from recruiting to completed as reported by CT.gov
    • 05 Oct 2008 Actual end date (June 2008) added as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top